[1] |
LI Min, LI Chunlei, SUN Cuicui, YU Wenwen, SUN Qing, QI Yingmei, LIU Anchang.
One Case of Acute Generalized Exanthematous Pustulosis Caused by Abrocitinib Tablets
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 823-825.
|
[2] |
ZHENG Changhui, MA Lina, HE Ting, GU Yuanyuan, ZHAO Wei, WANG Hongbin, NIU Yuanfei, FU Yao, CHEN Yanjun, CAO Junling.
Quality Evaluation and Control of Bupleuri Radix Decoction Pieces Based on ‘Shape-Chemistry-Biology' Sequential Detection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 197-205.
|
[3] |
JIA Juanjuan, SUN Jiabei, ZHANG Wenzai, SUN Deyang, SHI Yaqin, HUANG Haiwei.
Biological Distribution of 99mTc-DMSA Injection
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 47-52.
|
[4] |
SUN Li, XIE Bin, XU Yanqin.
Research progress of sustained and controlled release preparations of Chinese medicine
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 949-954.
|
[5] |
SUN Yue, HU Xinyue, LI Jing, ZHANG Wei, DING Xiaoli, ZHANG Hui, LIANG Chenggang.
Quality evaluation of desmopressin tablets and injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 632-637.
|
[6] |
DING Xiaoli, HU Xinyue, WANG Xuelei, SUN Yue, LI Jing, ZHANG Hui, Liang Chenggang, WANG Yan.
Quality evaluation of insulin glargine injections
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 644-650.
|
[7] |
JI Qiuxia, JIN Jian, ZHANG Bin.
Pharmaceutical care for immune-related adverse events induced by toripalimab
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 346-348.
|
[8] |
GUO Yijun, CHEN Xia, MENG Ping.
Adverse drug reaction reports in 141 cases of orally administered targeted anti-tumor drugs
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1137-1142.
|
[9] |
HUO Yanfei, TIAN Yuejie, XU Lili, XIE Yanjun, CHANG Hong, SUN Chunxiao, LI Xia.
535 reports of new and serious adverse drug reactions caused by preparations of lappaconitine hydrobromide
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 921-926.
|
[10] |
WANG Yadan, YAN Jiangong, CHEN Minghui, PANG Yu, DAI Zhong, MA Shuangcheng.
UPLC fingerprints of tripterygium glycosides tablets from different manufacturers
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 146-151.
|
[11] |
LIU Kecheng, WEI Tanjun, CHEN Fei, XIAO Cheng, ZHANG Yinsu.
Quality evaluation of Chaihu Shugan granules ria multi-component quantification combined with GRA and EW-TOPSIS method
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1243-1248.
|
[12] |
ZHUANG Hongyan, ZANG Yannan, LIU Shanshan, NIU Mengxi, FANG Meng, YIN Dongqing, GUO Wei.
Analysis of neuropsychiatric adverse reactions caused by zolpidem
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 889-892.
|
[13] |
WANG Ying, GU Donglin, FAN Jing, YANG Jianbo, LIU Yue, WANG Xueting, WANG Qi, JIN Hongyu, WEI Feng, MA Shuangcheng.
Changes of content of 5-HMF and stilbene glycoside in Polygoni Multiflori Radix during nine-time repeat of steaming and sun-drying
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(12): 1291-1294.
|
[14] |
MA Zhaozhao, WANG Qian, GAO Le, ZHEN Yaqin, WANG Xinguo, NIU Liying, ZHANG Liyan.
Study on Applicability of QAMS to Multi-component Content Determination of Citri Reticulatae Semen
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 637-640.
|
[15] |
LYU Tianyi, KUANG Li, CHEN Mingying.
Analysis of 1073 Cases of Clinical Use of Reduning Injection by Pareto Chart and Fishbone Diagram
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(10): 745-748.
|